Skip to main content

Table 2 Characterization of the immunological profile (n = 24)

From: Characterization and dynamics of the soluble immunological microenvironment in melanoma patients undergoing radiotherapy

 

Patients

Control

p

PD-L1

90.1

76.7

0.024

PD-L2

4.4

8.7

0.04

IL-6

8.5

0.6

0.052

CTLA-4

153.7

267.2

0.295

  1. Mean serum levels of inflammatory parameters compared between patients and healthy controls. PD-L1, IL-6 and CTLA-4 in pg/ml; PD-L2 in ng/ml. Significance was tested via two-sample t-tests
  2. CTLA, cytotoxic t-lymphocyte-associated protein; IL, Interleukin; PD-L, programmed death-ligand
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us